Jnana Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Jnana Therapeutics's estimated annual revenue is currently $17.2M per year.
- Jnana Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Jnana Therapeutics has 111 Employees.
- Jnana Therapeutics grew their employee count by 10% last year.
Jnana Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CMO and Head R&D | Reveal Email/Phone |
3 | VP Nonclinical Development | Reveal Email/Phone |
4 | SVP, Head Discovery Sciences | Reveal Email/Phone |
5 | VP, Head Early Discovery | Reveal Email/Phone |
6 | VP, Head Business Development | Reveal Email/Phone |
7 | VP and Head People & Culture | Reveal Email/Phone |
8 | Head R+D and CMO | Reveal Email/Phone |
9 | VP, Head Finance & Operations | Reveal Email/Phone |
10 | SVP & Head Biology | Reveal Email/Phone |
Jnana Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Jnana Therapeutics?
SLC transporters are the cell's metabolic gates, controlling the movement of metabolites in and out of cells and organelles. Metabolite homeostasis is often dysregulated in disease, and human biology points to SLC transporters as avenues to treat many indications. Jnana is building the first drug discovery platform dedicated to SLC transporters. This proprietary chemistry and biology platform allows the company to rapidly and comprehensively address therapeutic targets across the greater the 400-member membrane protein family.
keywords:N/A
N/A
Total Funding
111
Number of Employees
$17.2M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Jnana Therapeutics News
Cimeio Therapeutics, a novel cell therapy startup, announced the ... including chemoproteomic platform creator Jnana Therapeutics,...
Jnana Therapeutics, a Boston, Mass.-based biotechnology company utilizing its next generation chemoproteomic platform to target SLC transporters and other well-validated but hard-to-drug targets, closed a $50m Series B financing. The round was led by RA Capital Management, with participation fr ...
Jnana Therapeutics, a biotechnology company utilizing its next generation chemoproteomic platform to target SLC transporters and other well-validated but hard-to-drug targets, today announced the closing of a $50 million Series B financing. The financing was led by RA Capital Management, and inc ...
Jnana Therapeutics Inc., a Boston, MA-based developer of a drug discovery platform dedicated to targeting the solute carrier (SLC) family of transporters, the cell’s metabolic gates, raised $50m in Series A financing. Backers included Polaris Partners, Avalon Ventures, Versant Ventures, AbbVie ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20M | 111 | -15% | N/A |
#2 | $16.1M | 111 | 54% | N/A |
#3 | $17.8M | 111 | 7% | N/A |
#4 | $13.3M | 111 | 9% | N/A |
#5 | $16.7M | 111 | 0% | N/A |